At this point in time assume that everything coming out of their corner is pure BS. Starting with anything on ESS (if it ever actually happens), is not a reason to invest in AMBS. Revenue is the only answer at this point. The market knows and is aware of G'boy and his "uplist from strength" mantra and consequential evaporation of shareholder value. There is NOTHING that will attract retail investors to this company. At least when we invested, there really wasn't a track record to look at and we were just assuming that the guy leading the company was telling the truth. In hindsight, we were WRONG! Zero credibility equals zero new shareholders, retail or otherwise.
Again, I reiterate, the technology AMBS has is being passed over by newer and better technology. It is a total penny stock sham and has been manipulated into the ground all the while, the CEO takes a hefty paycheck all the way to the bank. Screw that guy!!!!!!!
(5)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links